Daniel F. Sansone
Known title: DirectorCIK: 0001327125
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Ingevity sets Q3 2026 earnings date; article discusses holding reasons. Ingevity announced the dates for its third‑quarter 2026 earnings release and the accompanying webcast. A recent Yahoo article outlined several points that investors have cited for maintaining their positions in the company. The upcoming earnings call may provide additional data that could influence market views.
Transaction History
| ASIX | ▲ Buy | Grant | 5,020 | $0 | 6/18/2025 | View on chart |
| NGVT | ▲ Buy | Grant | 4,057 | $0 | 5/1/2025 | View on chart |
| ASIX | ▲ Buy | Grant | 4,393 | $0 | 6/11/2024 | View on chart |
| NGVT | ▲ Buy | Grant | 2,800 | $0 | 4/24/2024 | View on chart |
| ASIX | ▲ Buy | Grant | 2,975 | $0 | 6/15/2023 | View on chart |
| NGVT | ▲ Buy | Grant | 1,645 | $0 | 4/28/2023 | View on chart |
| ASIX | ▲ Buy | Grant | 2,714 | $0 | 6/15/2022 | View on chart |
| NGVT | ▲ Buy | Grant | 1,942 | $0 | 4/28/2022 | View on chart |
| ASIX | ▲ Buy | Grant | 607 | $26K | 12/17/2021 | View on chart |
| ASIX | ▼ Sell | Gift | 9,000 | $0 | 10/22/2021 | View on chart |
| ASIX | ▼ Sell | Gift | 9,000 | $0 | 10/22/2021 | View on chart |
| ASIX | ▼ Sell | Gift | 11,439 | $0 | 10/15/2021 | View on chart |
| ASIX | ▼ Sell | Gift | 11,439 | $0 | 10/15/2021 | View on chart |
| ASIX | ▼ Sell | Gift | 11,040 | $0 | 10/14/2021 | View on chart |
| ASIX | ▼ Sell | Gift | 11,040 | $0 | 10/14/2021 | View on chart |
| ASIX | ▲ Buy | Grant | 661 | $26K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
AdvanSix Featured in Chemical Stocks With Natural Gas Cost Edge
AdvanSix (ASIX) was included in a recent article highlighting three US chemical stocks that benefit from lower natural gas costs. This cost advantage is relevant to the company's production expenses in the specialty chemicals sector. The stock is currently trading below its average analyst target price, with a 52-week range extending from $14.10 to $26.73.
AdvanSix Featured in Chemical Stocks With Natural Gas Cost Edge. AdvanSix (ASIX) was included in a recent article highlighting three US chemical stocks that benefit from lower natural gas costs. This cost advantage is relevant to the company's production expenses in the specialty chemicals sector. The stock is currently trading below its average analyst target price, with a 52-week range extending from $14.10 to $26.73.